Patient with melanoma receives tumor-infiltrating lymphocyte therapy
February 18, 2026
February 18, 2026
NASHVILLE, Tennessee, Feb. 18 -- Vanderbilt University Medical Center issued the following news release:
* * *
Patient with melanoma receives tumor-infiltrating lymphocyte therapy
*
Vanderbilt-Ingram Cancer Center has treated its first patient in a newly launched therapy program that magnifies the power of a person's natural defense system against tumors.
Tumor-infiltrating lymphocyte (TIL) therapy involves isolating the whit . . .
* * *
Patient with melanoma receives tumor-infiltrating lymphocyte therapy
*
Vanderbilt-Ingram Cancer Center has treated its first patient in a newly launched therapy program that magnifies the power of a person's natural defense system against tumors.
Tumor-infiltrating lymphocyte (TIL) therapy involves isolating the whit . . .